DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Tata Chemicals Limited — Chapter VIII - Specifications related to ISIN for debt

NSE 1 hr ago·13 Oct 2026, 10:11 am

Tata Chemicals

Tata Chemicals has updated its debt securities' specifications to align with the new ISIN (International Securities Identification Number) regulations. This change involves amending the details for its outstanding debt instruments to ensure they meet the updated regulatory standards.

This update is a routine administrative process required for compliance with market regulations. It does not alter the financial obligations of the company or the terms of its debt. For investors, this means the identification codes for these securities will be updated in records, but the underlying value and rights of the debt remain unchanged.

Investors should monitor the company's future announcements for any further updates related to this compliance. This change is primarily a technical adjustment and is not expected to impact the company's financial performance or the trading of its shares.